Info Obat dan Regulator Obat Dunia

F
FDA NanoDay Symposium 2022 - 10/11/2022
Replies
0
Views
581
FDA
F
F
Tissue Agnostic Drug Development in Oncology
Replies
0
Views
637
FDA
F
F
Rare Neurodegenerative Disease Grant Program
Replies
0
Views
569
FDA
F
E
New vaccine to protect people in the EU and worldwide against dengue , CHMP, 14/10/2022
Replies
0
Views
603
EMA
E
E
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 10-13 October 2022, CHMP, 14/10/2022
Replies
0
Views
632
EMA
E
E
First therapy to treat transplant patients with post-transplant lymphoproliferative disease, CHMP, 14/10/2022
Replies
0
Views
596
EMA
E
F
Exela Pharma Sciences, LLC Issues Voluntary Nationwide Recall of Sodium Bicarbonate Injection, USP, 8.4%, 50 mEq/50 mL Vial, 20-Count Carton Due to Vi
Replies
0
Views
568
FDA
F
F
FDA Seeks Feedback on Distributed and Point-of-Care Drug Manufacturing
Replies
0
Views
538
FDA
F
F
Distributed Manufacturing and Point-of-Care Manufacturing of Drugs | Discussion Paper
Replies
0
Views
536
FDA
F
F
FDA-CDER-CDRH, SNMMI, and MITA Workshop | Quantitative Brain Amyloid PET Imaging in Patients with Alzheimer’s Disease - 11/17/2022
Replies
0
Views
745
FDA
F
F
Sunscreen Protection - “Don’t Get Burned” Health Playbook BASKETALL Transcript
Replies
0
Views
785
FDA
F
F
Comparability Protocols for Postapproval Changes to the Chemistry, Manufacturing, and Controls Information in an NDA, ANDA, or BLA
Replies
0
Views
557
FDA
F
F
ANDA Submissions – Prior Approval Supplements Under GDUFA
Replies
0
Views
698
FDA
F
F
UPDATED INFORMATION: October 17 – 19, 2022: Hearing Announcement involving the Obstetrics, Reproductive, and Urologic Drugs Advisory Committee - 10/17
Replies
0
Views
734
FDA
F
F
Study Data Standards Update for CBER: Your Guide to a Successful Submission - 10/05/2022
Replies
0
Views
558
FDA
F
F
GDUFA III Enhancements to the Pre-ANDA Program
Replies
0
Views
568
FDA
F
F
Remarks by FDA Commissioner Robert Califf to Health Connect South - 09/22/2022
Replies
0
Views
552
FDA
F
F
ANDA Assessment Program – GDUFA III Performance Goals and Program Enhancements
Replies
0
Views
708
FDA
F
F
FDA Announces Shortage of Adderall
Replies
0
Views
581
FDA
F
E
High-quality data to empower data-driven medicines regulation in the European Union, , 10/10/2022
Replies
0
Views
587
EMA
E
You must log in or register to post here.
Top